You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Moesin Expression in Clear Cell Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
  • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
  • (no location specified)
Sep 20, 2023

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • ST-1898 tablets
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Nov 6, 2023

    Renal Cell Carcinoma Trial (HS-10516)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 24, 2023

    Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab injection
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 20, 2023

    Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

    Not yet recruiting
    • Papillary Renal Cell Carcinoma
    • (no location specified)
    Nov 24, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 28, 2023

    Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +3 more
    • Chengdu, Sichuan, China
      West China Hospital
    Apr 10, 2023

    Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

    Available
    • Clear Cell Renal Cell Carcinoma
    • 89Zr-DFO-girentuximab
    • Los Angeles, California
      UCLA
    Oct 12, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 18, 2023

    Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Cytoreductive Nephrectomy
    • (no location specified)
    Jul 3, 2023

    Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

    Recruiting
    • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
    • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
    • Shanghai, Shanghai, China
      Shanghai Renji Hospital
    Sep 12, 2023

    Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pucotenlimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 10, 2023

    Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

    Not yet recruiting
    • Advanced Clear Cell Renal Carcinoma (Ccrcc)
    • Papillary Renal Cell Carcinoma (Prcc)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 19, 2023

    Oligometastatic Renal Cell Carcinoma Trial in Houston (Pembrolizumab, Radiation therapy)

    Not yet recruiting
    • Oligometastatic Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 21, 2023

    Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

    Not yet recruiting
    • Renal Cancer
    • +3 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jul 24, 2023

    Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Sodium Pentaborate
    • Tabriz, East Azarbayejan, Iran, Islamic Republic of
      Imam Reza hospital and Clinic of Salamat
    Mar 23, 2023

    RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

    Not yet recruiting
    • RCC
    • Renal Cell Carcinoma
    • Cabozantinib 80 MG
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 3, 2023

    Learn About First and Later Lines of Medicines in Treating

    Completed
    • Metastatic Renal Cell Carcinoma
      • New York, New York
        Pfizer Headquarters
      May 12, 2023